MI
Co-founder and CEO.
Angel investor in early-stage technology companies; Limited Partner.
Licensed 100+ frontier AI assets to Fortune 10, life sciences and government, spanning from natural language understanding for national security applications to mechanistic toxicity prediction for drug discovery.
Startup mentor.
Developed and licensed IP on large-scale bio knowledge mining for a major EU agency.
Strategic AI research for a large non-commercial agency.
Developed and licensed IP on low-latency AI compute for a next-gen embedded AR product.
Developed and licensed IP on improved recovery of endothelial progenitor cells (EPCs).
Confidential.
Developed and licensed IP on large-scale human-machine collaboration.